Frontlight ResearchEarly access
Pompe disease trials in United Kingdom
2 of 5 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleStudy of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
- Where
- Birmingham, London, Newcastle upon Tyne, Salford
- Age
- 18 years and over
- People
- 45 worldwide
- Run by
- Shionogi
See details and how to joinNCT07123155 - Phase 3Taking peopleA Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
- Where
- London
- Age
- Up to 17 years
- People
- 36 worldwide
- Run by
- Amicus Therapeutics
See details and how to joinNCT04808505 · EU 2022-501095-25-01